Return to search

Optherion Raises $37 Million

Optherion Inc., a New Haven, Conn.-based developer of products to diagnose and treat dry and wet age-related macular degeneration, has raised $37 million in first-round funding. Backers include Quaker BioVentures, Domain Associates, Johnson & Johnson Development Corp., Purdue Pharmaceutical Products, Pappas Ventures, Biogen Idec New Ventures, and GE Healthcare Financial Services. www.optherion.com